121 related articles for article (PubMed ID: 17607590)
1. Plasma levels of some blood coagulation parameters in Nigerian homozygous sickle cell patients (HbSS) in steady state.
Buseri FI; Jeremiah ZA; Shokunbi WA
Hematology; 2006 Oct; 11(5):375-9. PubMed ID: 17607590
[TBL] [Abstract][Full Text] [Related]
2. Plasma levels of some coagulation parameters in steady state HBSC disease patients.
Ajuwon MD; Olayemi E; Benneh AA
Pan Afr Med J; 2014; 19():289. PubMed ID: 25870744
[TBL] [Abstract][Full Text] [Related]
3. Coagulation profile of children with sickle cell anemia in steady state and crisis attending the university of Nigeria teaching hospital, Ituku-Ozalla, Enugu.
Chinawa JM; Emodi IJ; Ikefuna AN; Ocheni S
Niger J Clin Pract; 2013; 16(2):159-63. PubMed ID: 23563454
[TBL] [Abstract][Full Text] [Related]
4. Relevance of fibrinolytic protein (D-dimer) and fibrinopeptide A as markers of sickle cell anaemia vaso-occlusive crisis.
Ekwere TA; Ebele U; Ekanem M; Ogunro PS
Niger Postgrad Med J; 2014 Sep; 21(3):225-30. PubMed ID: 25331238
[TBL] [Abstract][Full Text] [Related]
5. Plasma fibrinogen levels in Nigerian homozygous (Hb SS) sickle cell patients.
Buseri FI; Shokunbi WA; Jeremiah ZA
Hemoglobin; 2007; 31(1):89-92. PubMed ID: 17365009
[TBL] [Abstract][Full Text] [Related]
6. Plasma factor VII and thrombin-antithrombin III levels indicate increased tissue factor activity in sickle cell patients.
Kurantsin-Mills J; Ofosu FA; Safa TK; Siegel RS; Lessin LS
Br J Haematol; 1992 Aug; 81(4):539-44. PubMed ID: 1390242
[TBL] [Abstract][Full Text] [Related]
7. Plasma fibrinogen levels in sickle cell disease.
Famodu AA; Reid HL
Trop Geogr Med; 1987 Jan; 39(1):36-8. PubMed ID: 3603689
[TBL] [Abstract][Full Text] [Related]
8. Fibrinolytic activity in adult Kenyan patients with sickle cell disease.
Aluoch JR
East Afr Med J; 1998 Jun; 75(6):351-2. PubMed ID: 9803619
[TBL] [Abstract][Full Text] [Related]
9. Plasma fibrinolytic activity in sickle cell disease.
Famodu AA
Trop Geogr Med; 1988 Oct; 40(4):331-3. PubMed ID: 3227553
[TBL] [Abstract][Full Text] [Related]
10. C1 inhibitor, C3 activator, IgG, IgA, and IgM titers in Nigerian sickle cell disease patients with plasmodium falciparum.
Arinola G; Ezeh C
Iran J Immunol; 2007 Mar; 4(1):44-9. PubMed ID: 17652843
[TBL] [Abstract][Full Text] [Related]
11. Abnormality of erythrocyte membrane n-3 long chain polyunsaturated fatty acids in sickle cell haemoglobin C (HbSC) disease is not as remarkable as in sickle cell anaemia (HbSS).
Ren H; Ghebremeskel K; Okpala I; Ugochukwu CC; Crawford M; Ibegbulam O
Prostaglandins Leukot Essent Fatty Acids; 2006 Jan; 74(1):1-6. PubMed ID: 16314081
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the procoagulant activity of endogenous phospholipids in the platelet-free plasma of children with sickle cell disease using functional assays.
Noubouossie DC; Lê PQ; Rozen L; Debaugnies F; Ferster A; Demulder A
Thromb Res; 2012 Aug; 130(2):259-64. PubMed ID: 22079446
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of Foetal Haemoglobin Status among Nigerian Patients with Sickle Cell Anaemia Using High Performance Liquid Chromatography.
Ugwu NI; Nna EO; Ugwu CN; Ogah OE; Okike C; Ikeagwulonu RC; Nnadozie UU; Madu AJ; Okoye HC; Uzoma IC; Alo C; Ugwu GC; Ekpeagu VN; Okeke UI
West Afr J Med; 2021 Mar; 38(3):222-227. PubMed ID: 33765368
[TBL] [Abstract][Full Text] [Related]
14. Thrombin generation reveals high procoagulant potential in the plasma of sickle cell disease children.
Noubouossie DF; Lê PQ; Corazza F; Debaugnies F; Rozen L; Ferster A; Demulder A
Am J Hematol; 2012 Feb; 87(2):145-9. PubMed ID: 22052675
[TBL] [Abstract][Full Text] [Related]
15. Patients with sickle cell disease have reduced blood antioxidant protection.
Ren H; Ghebremeskel K; Okpala I; Lee A; Ibegbulam O; Crawford M
Int J Vitam Nutr Res; 2008 May; 78(3):139-47. PubMed ID: 19003736
[TBL] [Abstract][Full Text] [Related]
16. Clinical impact of factor V Leiden, prothrombin G20210A, and MTHFR C677T mutations among sickle cell disease patients of Central India.
Nishank SS; Singh MP; Yadav R
Eur J Haematol; 2013 Nov; 91(5):462-6. PubMed ID: 23992124
[TBL] [Abstract][Full Text] [Related]
17. Red blood cell lactate transport in sickle disease and sickle cell trait.
Pattillo RE; Gladden LB
J Appl Physiol (1985); 2005 Sep; 99(3):822-7. PubMed ID: 15890755
[TBL] [Abstract][Full Text] [Related]
18. The acceleration of the propagation phase of thrombin generation in patients with steady-state sickle cell disease is associated with circulating erythrocyte-derived microparticles.
Gerotziafas GT; Van Dreden P; Chaari M; Galea V; Khaterchi A; Lionnet F; Stankovic-Stojanovic K; Blanc-Brude O; Woodhams B; Maier-Redelsperger M; Girot R; Hatmi M; Elalamy I
Thromb Haemost; 2012 Jun; 107(6):1044-52. PubMed ID: 22535498
[TBL] [Abstract][Full Text] [Related]
19. Blood mononuclear cells and platelets have abnormal fatty acid composition in homozygous sickle cell disease.
Ren H; Okpala I; Ghebremeskel K; Ugochukwu CC; Ibegbulam O; Crawford M
Ann Hematol; 2005 Sep; 84(9):578-83. PubMed ID: 15809883
[TBL] [Abstract][Full Text] [Related]
20. Negative Epistasis between Sickle and Foetal Haemoglobin Suggests a Reduction in Protection against Malaria.
Mmbando BP; Mgaya J; Cox SE; Mtatiro SN; Soka D; Rwezaula S; Meda E; Msaki E; Snow RW; Jeffries N; Geller NL; Makani J
PLoS One; 2015; 10(5):e0125929. PubMed ID: 25965586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
